Share price is making a comeback after free falling in Jan. Challenge is in valuing this kind of unusual biz. However fr reading up a no. Of articles it looks like there is some margin of safety at 21-25 cents. Dyodd. Operating loss is expected quarterly ...
Exits may happen anytime & cause a spike in share especially if they announce a special dividend. Dyodd hor.
Trendlines expect most of the potential exits to come from medtech companies this year. While three medtech companies have engaged investment bankers to find potential buyers. One of them is already in an advanced stage and could stage exit in the next 3-4 month.
Just one exit will definitely cause the share price to spike. This year alone three medtech companies are ready to exist. Therefore the upside for the share price to increase is very high.
As a matter of fact: Trendlines had an exit ( PolyTouch) in 2011;
2 exits in 2013 ( FlowSense & Innolap )
2 exits in 2014 (Inspiro & an undisclosed exit).
There are potentially 3 exits in 2016 as three portfolio companies of Trendlines have signed letters of engagement with investment bankers. I expect the market to re-rate Trendlines share price on news of a confirmed exit, especially if the sale price far exceeds the book value of the company. This is to be expected because of the apparently conservative nature of the valuation of book value adopted by Trendlines.